Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Case reports in obstetrics and gynecology · 2026
    AHAlexandra HamiltonJHJudy HayekHLHani Lamie Ashamalla
    PMID: 42112520PMCID: PMC13157308DOISenior author

Publications

24 publications

Clinical research

10 studies

Active

1 study
  • PI
    The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
    PHASE3 · NRG Oncology · OPEN TO ACCRUAL (as of 2025)
    Prostate Adenocarcinoma; Stage III Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8
    NCT05946213
Completed & closed trials (9)
  • PI
    Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases
    PHASE3 · NRG Oncology · CLOSED TO ACCRUAL (as of 2026)
    Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Metastatic Digestive System Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Neoplasm in the Brain; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Renal Cell Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8
    NCT06500455
  • PI
    A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
    PHASE3 · ECOG-ACRIN Cancer Research Group · CLOSED TO ACCRUAL (as of 2026)
    Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8; Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    NCT03811015
  • PI
    A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases
    PHASE3 · NRG Oncology · CLOSED TO ACCRUAL (as of 2025)
    Metastatic Malignant Neoplasm in the Brain
    NCT05438212
  • PI
    Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
    PHASE2; PHASE3 · NRG Oncology · IRB STUDY CLOSURE (as of 2025)
    Extensive Stage Small Cell Lung Carcinoma; Limited Stage Small Cell Lung Carcinoma
    NCT02635009
  • PI
    A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
    PHASE3 · SWOG Cancer Research Network · CLOSED TO ACCRUAL (as of 2024)
    Lung Non-Small Cell Carcinoma; Stage I Lung Cancer AJCC v8; Stage II Lung Cancer AJCC v8
    NCT04214262
  • PI
    Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
    PHASE2 · NRG Oncology · IRB STUDY CLOSURE (as of 2024)
    HER2-Positive Breast Carcinoma; Invasive Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7
    NCT01622868
  • PI
    TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
    PHASE3 · Canadian Cancer Trials Group · CLOSED TO ACCRUAL (as of 2024)
    Breast Cancer
    NCT03488693
  • PI
    Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
    PHASE3 · NRG Oncology · CLOSED TO ACCRUAL (as of 2024)
    Prostate Adenocarcinoma
    NCT05050084
  • PI
    A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
    PHASE2 · NRG Oncology · CLOSED TO ACCRUAL (as of 2020)
    Recurrent Prostate Carcinoma; Stage III Prostate Adenocarcinoma AJCC v7; Stage IV Prostate Adenocarcinoma AJCC v7
    NCT03371719